Although given opportunities to continue a successful career within larger pharma organizations, Mr. Ladd chose to return to a younger, innovative company that has a proven track record within the industry. We are honored that he has chosen to return.
Olyphant, PA (PRWEB) January 29, 2009
Calvert Labs, a Calvert Holdings, Inc. company, announced today the hiring of Mr. Terry Ladd as Vice President of Business Development. Mr. Ladd had worked at Calvert Labs from 1994-2003 as Executive Director, Business Development and Marketing.
Mr. Ladd will be responsible for the sales and marketing of preclinical services in North America. With his many years of experience in the drug development/contract research organization field, he brings significant wisdom and experience to the table to help clients attain their goals in drug development in a timely and proper manner.
In addition to earning an MBA from McGill University and an MA from the University of Sherbrooke, Mr. Ladd's well-rounded background includes experience managing the sales, marketing, business development, finance, and administration functions for companies as varied as IMS Health, Guillevin International, Supertel Video Productions and General Electric.
Allan Reiss, President and COO of Calvert Holdings, Inc. remarked: "Although given opportunities to continue a successful career within larger pharma organizations, Mr. Ladd chose to return to a younger, innovative company that has a proven track record within the industry. We are honored that he has chosen to return." Mr. Ladd responded: "I am glad to be back with my former colleagues and look forward to the challenges and successes ahead."
About Calvert Labs:
Regarded by many as the premier IND-enabling contract research organization, Calvert Laboratories has been providing contract nonclinical services for almost four decades. As a global service provider, Calvert Labs' core offerings include toxicology (acute through chronic & carcinogenicity plus reproductive and developmental), pharmacokinetics & ADME, pharmacology, safety pharmacology, immunotoxicology and immunology. Located in northeastern Pennsylvania and easily accessible by major airlines, Calvert Labs provides services to companies in the biotechnology, pharmaceutical, and chemical industrial sectors.
About Calvert Holdings, Inc.
Formed in 1996, Calvert Holdings, Inc. is a privately-held company consisting of a diverse portfolio of companies including the following: Calvert Labs, Calvert Research, Calvert BioCapital, Calvert Creative, Carolina Securities, and Calvert Cafe. Calvert Holdings is a company of people who are passionately engaged in contributing to the future well being of the planet we live on. By analyzing how emerging discoveries and current trends will affect future global needs, we position resources and apply our skills to meet them.